nodes	percent_of_prediction	percent_of_DWPC	metapath
Brompheniramine—CYP2C8—Medroxyprogesterone Acetate—uterine cancer	0.157	0.173	CbGbCtD
Brompheniramine—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.109	0.121	CbGbCtD
Brompheniramine—CYP2C8—Progesterone—uterine cancer	0.104	0.115	CbGbCtD
Brompheniramine—CYP2C19—Progesterone—uterine cancer	0.087	0.0964	CbGbCtD
Brompheniramine—CYP2C9—Progesterone—uterine cancer	0.0723	0.0801	CbGbCtD
Brompheniramine—CYP2D6—Progesterone—uterine cancer	0.0661	0.0733	CbGbCtD
Brompheniramine—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0635	0.0703	CbGbCtD
Brompheniramine—CYP2E1—Etoposide—uterine cancer	0.0621	0.0688	CbGbCtD
Brompheniramine—CYP2C8—Etoposide—uterine cancer	0.0464	0.0514	CbGbCtD
Brompheniramine—CYP3A4—Progesterone—uterine cancer	0.0421	0.0466	CbGbCtD
Brompheniramine—CYP2B6—Doxorubicin—uterine cancer	0.0418	0.0463	CbGbCtD
Brompheniramine—CHRM3—ureter—uterine cancer	0.021	0.231	CbGeAlD
Brompheniramine—CYP2D6—Doxorubicin—uterine cancer	0.0202	0.0224	CbGbCtD
Brompheniramine—CYP3A4—Etoposide—uterine cancer	0.0188	0.0209	CbGbCtD
Brompheniramine—CHRM3—muscle of abdomen—uterine cancer	0.0151	0.167	CbGeAlD
Brompheniramine—CYP3A4—Doxorubicin—uterine cancer	0.0128	0.0142	CbGbCtD
Brompheniramine—CHRM3—exocrine gland—uterine cancer	0.00413	0.0456	CbGeAlD
Brompheniramine—CHRM5—epithelium—uterine cancer	0.00321	0.0355	CbGeAlD
Brompheniramine—KCNH2—myometrium—uterine cancer	0.00203	0.0224	CbGeAlD
Brompheniramine—CHRM3—smooth muscle tissue—uterine cancer	0.00173	0.0191	CbGeAlD
Brompheniramine—CHRM3—renal system—uterine cancer	0.00167	0.0184	CbGeAlD
Brompheniramine—HRH1—myometrium—uterine cancer	0.00163	0.018	CbGeAlD
Brompheniramine—KCNH2—uterine cervix—uterine cancer	0.00158	0.0174	CbGeAlD
Brompheniramine—CHRM1—female reproductive system—uterine cancer	0.00149	0.0165	CbGeAlD
Brompheniramine—KCNH2—renal system—uterine cancer	0.00148	0.0163	CbGeAlD
Brompheniramine—KCNH2—endometrium—uterine cancer	0.00143	0.0158	CbGeAlD
Brompheniramine—CYP2C8—renal system—uterine cancer	0.00135	0.0149	CbGeAlD
Brompheniramine—CHRM3—female reproductive system—uterine cancer	0.00133	0.0147	CbGeAlD
Brompheniramine—KCNH2—uterus—uterine cancer	0.00132	0.0145	CbGeAlD
Brompheniramine—CYP2C8—endometrium—uterine cancer	0.00131	0.0144	CbGeAlD
Brompheniramine—HRH1—epithelium—uterine cancer	0.00128	0.0141	CbGeAlD
Brompheniramine—HRH1—uterine cervix—uterine cancer	0.00127	0.014	CbGeAlD
Brompheniramine—HRH1—smooth muscle tissue—uterine cancer	0.00123	0.0136	CbGeAlD
Brompheniramine—CHRM3—female gonad—uterine cancer	0.00121	0.0134	CbGeAlD
Brompheniramine—CYP2B6—renal system—uterine cancer	0.00121	0.0134	CbGeAlD
Brompheniramine—HRH1—decidua—uterine cancer	0.00121	0.0133	CbGeAlD
Brompheniramine—KCNH2—female reproductive system—uterine cancer	0.00118	0.0131	CbGeAlD
Brompheniramine—HRH1—endometrium—uterine cancer	0.00115	0.0126	CbGeAlD
Brompheniramine—CYP2E1—renal system—uterine cancer	0.00114	0.0126	CbGeAlD
Brompheniramine—CYP2C19—vagina—uterine cancer	0.00112	0.0124	CbGeAlD
Brompheniramine—HRH1—mammalian vulva—uterine cancer	0.00111	0.0122	CbGeAlD
Brompheniramine—CYP2C8—female reproductive system—uterine cancer	0.00108	0.0119	CbGeAlD
Brompheniramine—KCNH2—female gonad—uterine cancer	0.00108	0.0119	CbGeAlD
Brompheniramine—KCNH2—vagina—uterine cancer	0.00107	0.0118	CbGeAlD
Brompheniramine—CYP2C8—vagina—uterine cancer	0.000979	0.0108	CbGeAlD
Brompheniramine—CYP2B6—female reproductive system—uterine cancer	0.000971	0.0107	CbGeAlD
Brompheniramine—CYP2C9—female reproductive system—uterine cancer	0.000962	0.0106	CbGeAlD
Brompheniramine—HRH1—female reproductive system—uterine cancer	0.000949	0.0105	CbGeAlD
Brompheniramine—CYP3A4—renal system—uterine cancer	0.000916	0.0101	CbGeAlD
Brompheniramine—CYP2E1—female reproductive system—uterine cancer	0.000911	0.0101	CbGeAlD
Brompheniramine—CYP2D6—renal system—uterine cancer	0.000901	0.00994	CbGeAlD
Brompheniramine—CYP2B6—vagina—uterine cancer	0.000878	0.00969	CbGeAlD
Brompheniramine—HRH1—female gonad—uterine cancer	0.000863	0.00952	CbGeAlD
Brompheniramine—HRH1—vagina—uterine cancer	0.000858	0.00947	CbGeAlD
Brompheniramine—CYP3A4—female reproductive system—uterine cancer	0.000733	0.00809	CbGeAlD
Brompheniramine—CYP2D6—female reproductive system—uterine cancer	0.000722	0.00796	CbGeAlD
Brompheniramine—KCNH2—lymph node—uterine cancer	0.000692	0.00764	CbGeAlD
Brompheniramine—CYP2D6—female gonad—uterine cancer	0.000657	0.00725	CbGeAlD
Brompheniramine—HRH1—lymph node—uterine cancer	0.000555	0.00612	CbGeAlD
Brompheniramine—CHRM5—Signaling Pathways—FGFR2—uterine cancer	3.5e-06	0.000512	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—RRM2—uterine cancer	3.34e-06	0.000489	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—AKR1B1—uterine cancer	3.34e-06	0.000489	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—STAR—uterine cancer	3.34e-06	0.000489	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—CYP11A1—uterine cancer	3.33e-06	0.000487	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—RRM2—uterine cancer	3.32e-06	0.000485	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—DCN—uterine cancer	3.25e-06	0.000475	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—STK11—uterine cancer	3.24e-06	0.000474	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—CYP19A1—uterine cancer	3.24e-06	0.000474	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—DCN—uterine cancer	3.22e-06	0.000471	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—STK11—uterine cancer	3.17e-06	0.000464	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—CYP19A1—uterine cancer	3.17e-06	0.000464	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—STK11—uterine cancer	3.17e-06	0.000463	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—STK11—uterine cancer	3.16e-06	0.000462	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—CCL2—uterine cancer	3.15e-06	0.000461	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—STK11—uterine cancer	3.15e-06	0.00046	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—CCL2—uterine cancer	3.14e-06	0.00046	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—AKR1C3—uterine cancer	3.14e-06	0.000459	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—CCL2—uterine cancer	3.13e-06	0.000458	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—ESR1—uterine cancer	3.13e-06	0.000458	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—STK11—uterine cancer	3.12e-06	0.000456	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—CCL2—uterine cancer	3.1e-06	0.000454	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—CYP11A1—uterine cancer	3.06e-06	0.000447	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—CYP11A1—uterine cancer	3.03e-06	0.000444	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—ESR1—uterine cancer	3e-06	0.000438	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—SOCS3—uterine cancer	2.97e-06	0.000434	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—SOCS3—uterine cancer	2.96e-06	0.000433	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—NRAS—uterine cancer	2.96e-06	0.000432	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—SOCS3—uterine cancer	2.95e-06	0.000431	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—SOCS3—uterine cancer	2.92e-06	0.000427	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—AKR1C3—uterine cancer	2.89e-06	0.000423	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—AKR1C3—uterine cancer	2.86e-06	0.000419	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CDKN2B—uterine cancer	2.84e-06	0.000415	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—NRAS—uterine cancer	2.83e-06	0.000414	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CDKN2B—uterine cancer	2.83e-06	0.000414	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—MTHFR—uterine cancer	2.83e-06	0.000414	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CDKN2B—uterine cancer	2.82e-06	0.000413	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CDKN2B—uterine cancer	2.79e-06	0.000409	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—IGF1R—uterine cancer	2.76e-06	0.000403	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—CCL2—uterine cancer	2.75e-06	0.000403	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—IGF1R—uterine cancer	2.75e-06	0.000402	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—CXCL8—uterine cancer	2.75e-06	0.000402	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—STK11—uterine cancer	2.74e-06	0.000401	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—CYP19A1—uterine cancer	2.74e-06	0.000401	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—IGF1R—uterine cancer	2.74e-06	0.000401	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—CXCL8—uterine cancer	2.74e-06	0.0004	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—CXCL8—uterine cancer	2.73e-06	0.000399	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—IGF1R—uterine cancer	2.71e-06	0.000397	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—CXCL8—uterine cancer	2.7e-06	0.000395	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—CCL2—uterine cancer	2.64e-06	0.000386	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—POLD1—uterine cancer	2.62e-06	0.000384	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—SMAD3—uterine cancer	2.59e-06	0.000379	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—SMAD3—uterine cancer	2.58e-06	0.000378	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—SMAD3—uterine cancer	2.58e-06	0.000377	CbGpPWpGaD
Brompheniramine—CHRM4—GPCR downstream signaling—PIK3CA—uterine cancer	2.57e-06	0.000377	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.57e-06	0.000376	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—SMAD3—uterine cancer	2.55e-06	0.000373	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—KRAS—uterine cancer	2.54e-06	0.000372	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—CXCL8—uterine cancer	2.49e-06	0.000365	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—CXCL8—uterine cancer	2.49e-06	0.000364	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—CXCL8—uterine cancer	2.48e-06	0.000362	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—FGFR2—uterine cancer	2.47e-06	0.000362	CbGpPWpGaD
Brompheniramine—CHRM5—GPCR downstream signaling—PIK3CA—uterine cancer	2.47e-06	0.000361	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—FGFR2—uterine cancer	2.47e-06	0.000361	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—FGFR2—uterine cancer	2.46e-06	0.000359	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.45e-06	0.000359	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—AKR1C1—uterine cancer	2.45e-06	0.000359	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—CXCL8—uterine cancer	2.45e-06	0.000359	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—CYP19A1—uterine cancer	2.45e-06	0.000358	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—STK11—uterine cancer	2.45e-06	0.000358	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—KRAS—uterine cancer	2.44e-06	0.000356	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—MTHFR—uterine cancer	2.43e-06	0.000356	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—FGFR2—uterine cancer	2.43e-06	0.000356	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—MTHFR—uterine cancer	2.38e-06	0.000349	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—PIK3CA—uterine cancer	2.34e-06	0.000342	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.3e-06	0.000336	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—ERBB2—uterine cancer	2.3e-06	0.000336	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—CYP19A1—uterine cancer	2.25e-06	0.000329	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—STK11—uterine cancer	2.25e-06	0.000329	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—PIK3CA—uterine cancer	2.24e-06	0.000327	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—STK11—uterine cancer	2.23e-06	0.000326	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—CYP19A1—uterine cancer	2.23e-06	0.000326	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—ERBB2—uterine cancer	2.2e-06	0.000322	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.19e-06	0.00032	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—RRM2—uterine cancer	2.19e-06	0.00032	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—CXCL8—uterine cancer	2.18e-06	0.000318	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—HRAS—uterine cancer	2.16e-06	0.000316	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—CDKN1B—uterine cancer	2.13e-06	0.000311	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—DCN—uterine cancer	2.12e-06	0.000311	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—ESR1—uterine cancer	2.12e-06	0.000309	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—ESR1—uterine cancer	2.11e-06	0.000309	CbGpPWpGaD
Brompheniramine—CHRM4—GPCR downstream signaling—AKT1—uterine cancer	2.1e-06	0.000308	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—ESR1—uterine cancer	2.1e-06	0.000308	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.09e-06	0.000306	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—CXCL8—uterine cancer	2.08e-06	0.000305	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—ESR1—uterine cancer	2.08e-06	0.000305	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—HRAS—uterine cancer	2.07e-06	0.000303	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—MTHFR—uterine cancer	2.06e-06	0.000301	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—CDKN1B—uterine cancer	2.04e-06	0.000298	CbGpPWpGaD
Brompheniramine—CHRM5—GPCR downstream signaling—AKT1—uterine cancer	2.01e-06	0.000295	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—CTNNB1—uterine cancer	2.01e-06	0.000294	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CYP11A1—uterine cancer	2e-06	0.000293	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—NRAS—uterine cancer	2e-06	0.000293	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2e-06	0.000292	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—NRAS—uterine cancer	1.99e-06	0.000292	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—NRAS—uterine cancer	1.99e-06	0.000291	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—NRAS—uterine cancer	1.97e-06	0.000288	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—PTEN—uterine cancer	1.96e-06	0.000286	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—CTNNB1—uterine cancer	1.92e-06	0.000281	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—AKT1—uterine cancer	1.91e-06	0.000279	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—AKR1C3—uterine cancer	1.89e-06	0.000276	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—PTEN—uterine cancer	1.87e-06	0.000274	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—EP300—uterine cancer	1.87e-06	0.000273	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CCL2—uterine cancer	1.86e-06	0.000272	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CCL2—uterine cancer	1.86e-06	0.000272	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CCL2—uterine cancer	1.85e-06	0.000271	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—MTHFR—uterine cancer	1.84e-06	0.000269	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CCL2—uterine cancer	1.83e-06	0.000268	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—AKT1—uterine cancer	1.83e-06	0.000268	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.82e-06	0.000266	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—EP300—uterine cancer	1.79e-06	0.000262	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—VEGFA—uterine cancer	1.77e-06	0.000259	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—NRAS—uterine cancer	1.75e-06	0.000255	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—PIK3CA—uterine cancer	1.74e-06	0.000255	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—PIK3CA—uterine cancer	1.74e-06	0.000254	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—PIK3CA—uterine cancer	1.73e-06	0.000253	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—KRAS—uterine cancer	1.72e-06	0.000252	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—KRAS—uterine cancer	1.72e-06	0.000251	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—PIK3CA—uterine cancer	1.71e-06	0.000251	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—KRAS—uterine cancer	1.71e-06	0.00025	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—KRAS—uterine cancer	1.69e-06	0.000248	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—VEGFA—uterine cancer	1.69e-06	0.000248	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—MTHFR—uterine cancer	1.69e-06	0.000247	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—MTHFR—uterine cancer	1.68e-06	0.000245	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—NRAS—uterine cancer	1.67e-06	0.000245	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.62e-06	0.000237	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—PIK3CA—uterine cancer	1.58e-06	0.000231	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—PIK3CA—uterine cancer	1.58e-06	0.000231	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—PTEN—uterine cancer	1.57e-06	0.00023	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—PIK3CA—uterine cancer	1.57e-06	0.00023	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—PIK3CA—uterine cancer	1.56e-06	0.000228	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—ERBB2—uterine cancer	1.55e-06	0.000227	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—ERBB2—uterine cancer	1.55e-06	0.000226	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—ERBB2—uterine cancer	1.54e-06	0.000226	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—ERBB2—uterine cancer	1.53e-06	0.000224	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—KRAS—uterine cancer	1.5e-06	0.00022	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—EP300—uterine cancer	1.5e-06	0.00022	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.48e-06	0.000216	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CXCL8—uterine cancer	1.47e-06	0.000215	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—STK11—uterine cancer	1.47e-06	0.000215	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CYP19A1—uterine cancer	1.47e-06	0.000215	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CXCL8—uterine cancer	1.47e-06	0.000215	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CXCL8—uterine cancer	1.46e-06	0.000214	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—HRAS—uterine cancer	1.46e-06	0.000214	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—HRAS—uterine cancer	1.46e-06	0.000213	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—HRAS—uterine cancer	1.45e-06	0.000213	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CXCL8—uterine cancer	1.45e-06	0.000212	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—HRAS—uterine cancer	1.44e-06	0.000211	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—KRAS—uterine cancer	1.44e-06	0.000211	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CDKN1B—uterine cancer	1.44e-06	0.00021	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CDKN1B—uterine cancer	1.43e-06	0.00021	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CDKN1B—uterine cancer	1.43e-06	0.000209	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—AKT1—uterine cancer	1.42e-06	0.000208	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—AKT1—uterine cancer	1.42e-06	0.000207	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CDKN1B—uterine cancer	1.42e-06	0.000207	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—AKT1—uterine cancer	1.41e-06	0.000207	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—AKT1—uterine cancer	1.4e-06	0.000205	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—PIK3CA—uterine cancer	1.38e-06	0.000202	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CTNNB1—uterine cancer	1.36e-06	0.000199	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CTNNB1—uterine cancer	1.35e-06	0.000198	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—PTEN—uterine cancer	1.35e-06	0.000198	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CTNNB1—uterine cancer	1.35e-06	0.000197	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CTNNB1—uterine cancer	1.34e-06	0.000196	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—TP53—uterine cancer	1.34e-06	0.000195	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—PTEN—uterine cancer	1.33e-06	0.000194	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—PTEN—uterine cancer	1.32e-06	0.000194	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—PIK3CA—uterine cancer	1.32e-06	0.000193	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—PTEN—uterine cancer	1.32e-06	0.000193	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—PTEN—uterine cancer	1.32e-06	0.000192	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—PTEN—uterine cancer	1.3e-06	0.000191	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—AKT1—uterine cancer	1.29e-06	0.000189	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—EP300—uterine cancer	1.29e-06	0.000189	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—AKT1—uterine cancer	1.29e-06	0.000188	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—AKT1—uterine cancer	1.28e-06	0.000188	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—TP53—uterine cancer	1.28e-06	0.000187	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—HRAS—uterine cancer	1.28e-06	0.000187	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—AKT1—uterine cancer	1.27e-06	0.000186	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—EP300—uterine cancer	1.26e-06	0.000185	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—EP300—uterine cancer	1.26e-06	0.000185	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—EP300—uterine cancer	1.26e-06	0.000184	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—EP300—uterine cancer	1.25e-06	0.000184	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—EP300—uterine cancer	1.24e-06	0.000182	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—HRAS—uterine cancer	1.22e-06	0.000179	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—VEGFA—uterine cancer	1.2e-06	0.000175	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—VEGFA—uterine cancer	1.19e-06	0.000174	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—VEGFA—uterine cancer	1.19e-06	0.000174	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—NRAS—uterine cancer	1.18e-06	0.000173	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—NRAS—uterine cancer	1.18e-06	0.000172	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—VEGFA—uterine cancer	1.18e-06	0.000172	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—NRAS—uterine cancer	1.17e-06	0.000172	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—NRAS—uterine cancer	1.16e-06	0.00017	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—PTEN—uterine cancer	1.15e-06	0.000168	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—AKT1—uterine cancer	1.13e-06	0.000165	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—PIK3CA—uterine cancer	1.11e-06	0.000162	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—MTHFR—uterine cancer	1.11e-06	0.000162	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—EP300—uterine cancer	1.09e-06	0.00016	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—AKT1—uterine cancer	1.08e-06	0.000158	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—PTEN—uterine cancer	1.02e-06	0.00015	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—KRAS—uterine cancer	1.02e-06	0.000149	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—KRAS—uterine cancer	1.01e-06	0.000148	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—KRAS—uterine cancer	1.01e-06	0.000148	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—KRAS—uterine cancer	1e-06	0.000146	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—EP300—uterine cancer	9.76e-07	0.000143	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—PIK3CA—uterine cancer	9.55e-07	0.00014	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PTEN—uterine cancer	9.41e-07	0.000138	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—PIK3CA—uterine cancer	9.35e-07	0.000137	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—PIK3CA—uterine cancer	9.34e-07	0.000137	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PTEN—uterine cancer	9.33e-07	0.000136	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—PIK3CA—uterine cancer	9.31e-07	0.000136	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—PIK3CA—uterine cancer	9.28e-07	0.000136	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—PIK3CA—uterine cancer	9.19e-07	0.000134	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—AKT1—uterine cancer	9.07e-07	0.000133	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—TP53—uterine cancer	9.04e-07	0.000132	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—TP53—uterine cancer	9.01e-07	0.000132	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—TP53—uterine cancer	8.98e-07	0.000131	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—EP300—uterine cancer	8.97e-07	0.000131	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—EP300—uterine cancer	8.9e-07	0.00013	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—TP53—uterine cancer	8.89e-07	0.00013	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—HRAS—uterine cancer	8.64e-07	0.000126	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—HRAS—uterine cancer	8.62e-07	0.000126	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—HRAS—uterine cancer	8.59e-07	0.000126	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—HRAS—uterine cancer	8.5e-07	0.000124	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—PIK3CA—uterine cancer	8.09e-07	0.000118	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—AKT1—uterine cancer	7.8e-07	0.000114	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—AKT1—uterine cancer	7.64e-07	0.000112	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—AKT1—uterine cancer	7.63e-07	0.000112	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—AKT1—uterine cancer	7.61e-07	0.000111	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—AKT1—uterine cancer	7.58e-07	0.000111	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—AKT1—uterine cancer	7.51e-07	0.00011	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—PIK3CA—uterine cancer	7.22e-07	0.000106	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PIK3CA—uterine cancer	6.64e-07	9.71e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—AKT1—uterine cancer	6.61e-07	9.66e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PIK3CA—uterine cancer	6.58e-07	9.63e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PTEN—uterine cancer	6.15e-07	9e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—AKT1—uterine cancer	5.9e-07	8.62e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—EP300—uterine cancer	5.87e-07	8.58e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—AKT1—uterine cancer	5.42e-07	7.93e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—AKT1—uterine cancer	5.38e-07	7.86e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PIK3CA—uterine cancer	4.34e-07	6.35e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—AKT1—uterine cancer	3.55e-07	5.19e-05	CbGpPWpGaD
